Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 22% ± 6% | |
smooth muscle cell | 4 studies | 16% ± 1% | |
astrocyte | 4 studies | 28% ± 7% | |
endothelial cell | 3 studies | 19% ± 3% | |
ciliated cell | 3 studies | 26% ± 7% | |
GABAergic neuron | 3 studies | 36% ± 3% | |
glutamatergic neuron | 3 studies | 55% ± 8% | |
oligodendrocyte | 3 studies | 20% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 38% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 477.93 | 1444 / 1445 | 100% | 12.24 | 183 / 183 |
ovary | 100% | 751.77 | 180 / 180 | 100% | 9.61 | 429 / 430 |
breast | 100% | 628.12 | 459 / 459 | 99% | 11.88 | 1112 / 1118 |
lung | 100% | 545.51 | 577 / 578 | 100% | 7.47 | 1150 / 1155 |
stomach | 100% | 410.52 | 358 / 359 | 100% | 9.67 | 285 / 286 |
intestine | 100% | 494.76 | 964 / 966 | 99% | 8.69 | 521 / 527 |
thymus | 100% | 520.14 | 651 / 653 | 98% | 8.58 | 595 / 605 |
prostate | 100% | 465.26 | 244 / 245 | 98% | 8.07 | 493 / 502 |
skin | 100% | 747.76 | 1809 / 1809 | 97% | 8.49 | 458 / 472 |
uterus | 100% | 620.67 | 170 / 170 | 97% | 7.14 | 444 / 459 |
bladder | 100% | 515.24 | 21 / 21 | 97% | 6.69 | 487 / 504 |
pancreas | 98% | 273.48 | 320 / 328 | 98% | 5.70 | 174 / 178 |
brain | 94% | 261.62 | 2474 / 2642 | 99% | 6.72 | 701 / 705 |
kidney | 100% | 344.20 | 89 / 89 | 91% | 6.07 | 819 / 901 |
adrenal gland | 100% | 525.14 | 258 / 258 | 90% | 4.97 | 208 / 230 |
liver | 97% | 239.60 | 219 / 226 | 73% | 2.71 | 295 / 406 |
adipose | 100% | 688.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 807.08 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1028.00 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 383.04 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.92 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 98% | 6.95 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 97% | 6.62 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 95% | 5.62 | 76 / 80 |
heart | 93% | 324.06 | 801 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 48% | 263.17 | 444 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043489 | Biological process | RNA stabilization |
GO_1904874 | Biological process | positive regulation of telomerase RNA localization to Cajal body |
GO_0000493 | Biological process | box H/ACA snoRNP assembly |
GO_0090669 | Biological process | telomerase RNA stabilization |
GO_1905323 | Biological process | telomerase holoenzyme complex assembly |
GO_0032212 | Biological process | positive regulation of telomere maintenance via telomerase |
GO_0042254 | Biological process | ribosome biogenesis |
GO_0051973 | Biological process | positive regulation of telomerase activity |
GO_0000454 | Biological process | snoRNA guided rRNA pseudouridine synthesis |
GO_1904358 | Biological process | positive regulation of telomere maintenance via telomere lengthening |
GO_0005732 | Cellular component | sno(s)RNA-containing ribonucleoprotein complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0070034 | Molecular function | telomerase RNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | NAF1 |
Protein name | Nef-associated factor 1 SNP Nuclear assembly factor 1 ribonucleoprotein H/ACA ribonucleoprotein complex non-core subunit NAF1 (hNAF1) |
Synonyms | |
Description | FUNCTION: RNA-binding protein required for the maturation of box H/ACA snoRNPs complex and ribosome biogenesis. During assembly of the H/ACA snoRNPs complex, it associates with the complex and disappears during maturation of the complex and is replaced by NOLA1/GAR1 to yield mature H/ACA snoRNPs complex. Probably competes with NOLA1/GAR1 for binding with DKC1/NOLA4. . |
Accessions | ENST00000509434.5 Q96HR8 D6RIB3 ENST00000422287.6 [Q96HR8-2] ENST00000274054.3 [Q96HR8-1] A4F1Y0 |